ADCENTRX THERAPEUTICS
Adcentrx is a biotechnology company focused on accelerating breakthroughs in protein conjugate therapeutic development for cancer and other life-threatening diseases. By combining the targeting precision of biologics and the disease fighting power of small molecule payloads, Adcentrx strives to develop next generation targeted therapies for improving patient treatment options.
ADCENTRX THERAPEUTICS
Social Links:
Industry:
Biotechnology Pharmaceutical
Founded:
2021-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.adcentrx.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
101 M USD
Technology used in webpage:
Google Maps CrUX Top 50m CrUX Dataset Google Maps API WooCommerce OpenStreetMap
Similar Organizations
1859
1859 is a biotechnology company focusing on the discovery and development of next-generation therapeutics.
Apic Bio
Apic Bio is a gene therapy company that develops treatment options for rare, undertreated neurological and liver diseases.
Aridis Pharmaceuticals
Aridis is a biopharmaceutical company focused on the development of novel, differentiated therapies for infectious diseases.
Dicerna Pharmaceuticals
Dicerna Pharmaceuticals is a biotechnology company with a focus on the development of innovative treatments for rare inherited diseases.
Mirum Pharmaceuticals
Mirum Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapies.
Phanes Therapeutics
Phanes Therapeutics is a biotech company focused on discovery and development of therapeutics for solid tumors and eye diseases
SalubrisBio
SalubrisBio is a clinical-stage biotechnology company dedicated to discovering and developing novel antibody and protein-based therapeutics.
Current Employees Featured
Founder
Investors List
Eight Roads Ventures
Eight Roads Ventures investment in Series A - Adcentrx Therapeutics
Partners Investment
Partners Investment investment in Series A - Adcentrx Therapeutics
Delta Capital
Delta Capital investment in Series A - Adcentrx Therapeutics
LIGHTHOUSE
LIGHTHOUSE investment in Series A - Adcentrx Therapeutics
Quan Capital
Quan Capital investment in Series A - Adcentrx Therapeutics
F-Prime Capital
F-Prime Capital investment in Series A - Adcentrx Therapeutics
Trinity Innovation Fund
Trinity Innovation Fund investment in Series A - Adcentrx Therapeutics
ABio-X
ABio-X investment in Series A - Adcentrx Therapeutics
CBC Group
CBC Group investment in Series A - Adcentrx Therapeutics
C-Bridge Capital
C-Bridge Capital investment in Series A - Adcentrx Therapeutics
Key Employee Changes
Date | New article |
---|---|
2024-04-08 | Adcentrx Therapeutics Appoints Meng Jiang as Chief Financial Officer |
Official Site Inspections
http://www.adcentrx.com Semrush global rank: 7.07 M Semrush visits lastest month: 902
- Host name: 216.70.215.35.bc.googleusercontent.com
- IP address: 35.215.70.216
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043

More informations about "Adcentrx Therapeutics"
Adcentrx Therapeutics - Crunchbase Company Profile โฆ
Adcentrx is a biotechnology company focused on accelerating breakthroughs in protein conjugate therapeutic development for cancer and other life-threatening diseases. By combining the targeting precision of biologics and the disease โฆSee details»
Management Team - Adcentrx Therapeutics
Prior to joining Adcentrx in 2022, he was Senior Director, Business Development at Halozyme Therapeutics, a public biotechnology company focused on enabling platforms for the โฆSee details»
Adcentrx Therapeutics, Inc. - Drug pipelines, Patents ... - Patsnap
Adcentrx Therapeutics, Inc. is a biotechnology firm based in San Diego, California, specializing in the development of protein conjugate therapeutics for cancer treatment. Founded by Hui Li, โฆSee details»
Adcentrx Therapeutics - Overview, News & Similar companies
Dec 5, 2023 Adcentrx Therapeutics contact info: Phone number: (858) 428-9505 Website: www.adcentrx.com What does Adcentrx Therapeutics do? Founded in 2021, headquartered in โฆSee details»
About - Adcentrx Therapeutics
At Adcentrx, we are driven to create the best therapies to treat serious and life-threatening diseases. By leveraging a deep understanding of chemistry and biology, our goal is to purposefully solve the issues faced by ADCs in the past โฆSee details»
Adcentrx Therapeutics Inc. Company Profile | San Diego, CA ...
Find company research, competitor information, contact details & financial data for Adcentrx Therapeutics Inc. of San Diego, CA. Get the latest business insights from Dun & Bradstreet.See details»
Adcentrx Therapeutics - Org Chart, Teams, Culture & Jobs - The Org
Adcentrx Therapeutics is a biotechnology company focused on accelerating breakthroughs in protein conjugate therapeutic development for cancer and other life-threatening diseases. By โฆSee details»
Adcentrx Therapeutics - Funding, Financials, Valuation & Investors
Adcentrx is a biotechnology company focused on therapeutic development for cancer and other life-threatening diseases. Search Crunchbase. Start Free Trial . ... How much funding has this โฆSee details»
Adcentrx Therapeutics Overview | SignalHire Company Profile
Adcentrx Therapeutics is a private company that has been in the industry for 3 years. The company currently specializes in the Biotechnology area. ... Organization Website: โฆSee details»
Adcentrx Therapeutics Company Profile 2024: Valuation, Funding ...
Adcentrx Therapeutics is headquartered in San Diego, CA. What is the size of Adcentrx Therapeutics? Adcentrx Therapeutics has 50 total employees. What industry is Adcentrx โฆSee details»
Adcentrx Therapeutics - VentureRadar
Adcentrx has pioneered the development of an ADC technology platform addressing key components of protein conjugate design to solve challenges typically seen in ADCs. In โฆSee details»
Adcentrx Therapeutics - Contacts, Employees, Board Members
Adcentrx is a biotechnology company focused on therapeutic development for cancer and other life-threatening diseasesSee details»
Adcentrx Therapeutics - Craft
Adcentrx Therapeutics has 5 employees across 2 locations and $51 m in total funding,. See insights on Adcentrx Therapeutics including office locations, competitors, revenue, financials, โฆSee details»
Adcentrx Therapeutics - Products, Competitors, Financials, โฆ
News provided by Share this article Dosing of first patient in a Phase 1a/b clinical trial anticipated by 4Q 2024 SAN DIEGO, Oct. 21, 2024 /PRNewswire/ -- Adcentrx Therapeutics ("Adcentrx"), โฆSee details»
Adcentrx Announces Extension of Series A+ ... - Adcentrx โฆ
Dec 5, 2023 Adcentrx is a biotechnology company focused on accelerating breakthroughs in protein conjugate therapeutic development for cancer and other life-threatening diseases. By โฆSee details»
Adcentrx Therapeutics - Crunchbase
Adcentrx Therapeutics, 1859, Phanes Therapeutics, Apic Bio, SalubrisBio, and Mirum Pharmaceuticals operate in the biotechnology sector. 1859, Phanes Therapeutics, Apic Bio, โฆSee details»
ADRX-0405 - Drug Targets, Indications, Patents - Synapse - Patsnap
3 days ago ADRX-0405: a STEAP1 modulators Drug, Initially developed by Adcentrx Therapeutics, Inc., Now, its global highest R&D status is Phase 1, Mechanism: STEAP1 โฆSee details»
Adcentrx Therapeutics Doses First Patient in Phase 1b
6 days ago Adcentrx is a biotechnology company focused on accelerating breakthroughs in protein conjugate therapeutic development for cancer and other life-threatening diseases. โฆSee details»
Adcentrx and AvantGen Enter a New Partnership ... - Adcentrx โฆ
Feb 14, 2022 Adcentrx Therapeutics (โAdcentrxโ), a biotechnology company focused on accelerating breakthroughs in antibody drug conjugate (โADCโ) therapeutic development, and โฆSee details»
Adcentrx Therapeutics Doses First Patient in Phase 1b Expansion โฆ
5 days ago The first-in-human Phase 1a/b study is an open-label, two-part trial being conducted at sites in the U.S. and China.The Phase 1a part consisted of a dose escalation of ADRX-0706 โฆSee details»